Author: YTT Admin
-
Trikafta for 6-11 going back to the PBAC
Disappointingly Trikafta for 6-11s is going back to the PBAC as an agreement has not been reached. It will be discussed this week with the outcome released on April 21. This is not good enough Mark Butler MPVertex Pharmaceuticals. Heading back to the standard PBAC process leads to further uncertainty with the approval and timeframe,…
-
Drugs were found
In a scary place
-
Listing progress update
The medicine status website was updated this week and shows that step 5 of 8 is underway. Whilst there are multiple parts within each step, the progress is underwhelming for those who are seriously unwell now. Some of these children are in hospital right now and urgently need access to Trikafta. Every day matters for…
-
Moments with family
When you have a life shortening illness, it’s all about the important moments with your family and friends. These children had to spend time in hospital over the festive season and missed those special moments. Trikafta is a life-saving medication that can change all this, giving these kids the chance to live a longer, healthier…
-
We need your help!
Have a read below about what happens after a PBAC meeting & what we can do to help fast track the listing! What happens after a PBAC meeting? After a positive recommendation, there are several steps before a medication can be listed on the PBS. Amongst these steps are the negotiations between the Department of…
-
It’s a yes!
Great news it’s a yes! Trikafta for children aged 6-11 has received a positive recommendation, moving much closer toward access However this recommendation has not been given a priority pathway for listing (which Trikafta for 12+ had), so we need to make sure the next step, involving further negotiations, happens as quickly as possible! The…